Extending DerSimonian and Laird's methodology to perform network meta‐analyses with random inconsistency effects
Dan Jackson(AstraZeneca (United Kingdom)), Ian R. White(MRC Clinical Trials Unit at UCL), Julian P. T. Higgins(University of Bristol), Martin Law(MRC Biostatistics Unit), Rebecca Turner(MRC Clinical Trials Unit at UCL), Georgia Salanti(University of Bern), Jessica Barrett(University of Leeds)
Cited by 47
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
|The Lancet|2013|2.5k
Graphical Tools for Network Meta-Analysis in STATA
|PLoS ONE|2013|2.5k